ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1173

G Protein Coupled Receptor Kinase 3 Regulation of Inflammatory Arthritis

Matthew J. Billard1, Roman Timoshchenko2, D. Stephen Serafin2 and Teresa K. Tarrant3, 1Medicine, University of North Carolina, Chapel Hill, NC, 2Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 3Rheumatology, University of North Carolina, Chapel Hill, NC

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Animal models, Chemokine Receptors, immunology and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:   Chemokine receptors are G Protein Coupled Receptor (GPCR) family members that direct cell migration, differentiation, and survival in inflammatory conditions, but neutralization strategies have had mixed results in autoimmunity and even less efficacy in Rheumatoid Arthritis (RA). This has been partially attributed to chemokine receptor/ligand redundancy in inflammation, and it has been proposed that a regulator of GPCR signaling should be targeted rather than neutralization of singular chemokines or their receptors.  G protein coupled receptor kinase 3 (GRK3) activity negatively regulates GPCR activation, but also helps recruit downstream signaling machinery to coordinate leukocyte responses. GRK3-deficient mice were previously shown to be protected from disease in two acute models of inflammatory arthritis (K/BxN serum transfer and Collagen Antibody Induced Arthritis) by altering granulocyte migration and innate responses.  In this study, we examine the effects of GRK3 knockdown in the chronic, HLA-restricted Collagen Induced Arthritis (CIA) model.

Methods:   The Collagen-Induced Arthritis (CIA) model of inflammatory arthritis was used to test in vivo disease progression in GRK3-deficient DBA mice.  To examine the biological basis for protection in GRK3 knockout mice, an interdisciplinary approach was used.  Traditional migration and survival assays were performed on leukocytes ex vivo and a mathematical model of GRK3 signal regulation was developed.

Results:   Results showed that GRK3-deficient DBA mice are protected from developing CIA in vivo. Serum antibody is decreased in GRK3-deficient mice and PCR of the joint revealed greatly reduced levels of IL-17, IL-23, TNFα, and IL-1β transcript expression, suggesting a lack of inflammatory cell infiltration. Ex vivo assays describe altered migration and survival of immune cells.  A mathematical model was created to further examine and test the mechanisms of signal regulation.

Conclusion: Proinflammatory functions of leukocytes critical to RA development require GRK3 function. Having a single protein target for RA therapeutic intervention that appears to selectively prevent infiltration into the joint represents a compelling target for therapeutic attempts at single cytokine or chemokine neutralization.


Disclosure: M. J. Billard, None; R. Timoshchenko, None; D. S. Serafin, None; T. K. Tarrant, None.

To cite this abstract in AMA style:

Billard MJ, Timoshchenko R, Serafin DS, Tarrant TK. G Protein Coupled Receptor Kinase 3 Regulation of Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/g-protein-coupled-receptor-kinase-3-regulation-of-inflammatory-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/g-protein-coupled-receptor-kinase-3-regulation-of-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology